| Nanoplatforms for cancer theranostics | Lifetime | 1 | PL 1 | 99.99 |
| Graphene and Nanomaterials Applications | Lifetime | 1 | PL 1 | 99.99 |
| Nanoparticle-Based Drug Delivery | Lifetime | 4 | PL 1 | 99.98 |
| Advanced Nanomaterials in Catalysis | Lifetime | 16 | PL 1 | 99.85 |
| Extracellular vesicles in disease | Lifetime | 19 | PL 1 | 99.65 |
| Photoacoustic and Ultrasonic Imaging | Lifetime | 34 | PL 1 | 99.56 |
| RNA Interference and Gene Delivery | Lifetime | 97 | PL 1 | 99.63 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 107 | PL 1 | 99.58 |
| Carbon and Quantum Dots Applications | Lifetime | 21 | PL 1 | 99.35 |
| Photodynamic Therapy Research Studies | Lifetime | 24 | PL 1 | 99.37 |
| Advanced biosensing and bioanalysis techniques | Lifetime | 147 | PL 1 | 99.56 |
| Immune cells in cancer | Lifetime | 155 | PL 1 | 99.00 |
| Immunotherapy and Immune Responses | Lifetime | 441 | PL 2 | 99.26 |
| Luminescence and Fluorescent Materials | Lifetime | 229 | PL 1 | 99.10 |
| Luminescence Properties of Advanced Materials | Lifetime | 237 | PL 5 | 98.64 |
| MXene and MAX Phase Materials | Lifetime | 292 | PL 1 | 98.48 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 918 | PL 2 | 98.11 |
| Carbon Nanotubes in Composites | Lifetime | 461 | PL 2 | 97.99 |
| Cancer Research and Treatments | Lifetime | 699 | PL 1 | 96.71 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 619 | PL 5 | 90.71 |
| Molecular Communication and Nanonetworks | Lifetime | 594 | PL 3 | 85.48 |
| Hydrogen's biological and therapeutic effects | Lifetime | 484 | PL 4 | 80.41 |
| Immunotherapy and Immune Responses | 2021-2025 | 6 | PL 1 | 99.75 |
| Immune cells in cancer | 2021-2025 | 7 | PL 1 | 99.61 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 11 | PL 1 | 99.93 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 25 | PL 1 | 98.67 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 36 | PL 1 | 98.93 |
| Extracellular vesicles in disease | 2021-2025 | 64 | PL 1 | 98.26 |
| RNA Interference and Gene Delivery | 2021-2025 | 57 | PL 1 | 98.66 |
| Cancer Research and Treatments | 2021-2025 | 29 | PL 1 | 97.77 |
| Immune Cell Function and Interaction | 2021-2025 | 255 | PL 1 | 96.45 |
| Advanced Nanomaterials in Catalysis | 2021-2025 | 344 | PL 1 | 96.66 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 729 | PL 4 | 97.21 |
| Graphene and Nanomaterials Applications | 2021-2025 | 179 | PL 2 | 95.89 |
| interferon and immune responses | 2021-2025 | 194 | PL 1 | 92.26 |
| Phagocytosis and Immune Regulation | 2021-2025 | 77 | PL 1 | 91.02 |
| Photodynamic Therapy Research Studies | 2021-2025 | 157 | PL 7 | 92.86 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 654 | PL 9 | 87.09 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 292 | PL 3 | 88.47 |
| Photoacoustic and Ultrasonic Imaging | 2021-2025 | 710 | PL 4 | 86.90 |
| Advanced Drug Delivery Systems | 2021-2025 | 688 | PL 6 | 83.58 |
| Vascular Malformations and Hemangiomas | 2021-2025 | 320 | PL 1 | 75.30 |
| Hydrogen's biological and therapeutic effects | 2021-2025 | 142 | PL 1 | 73.43 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 505 | PL 6 | 68.62 |
| Dendrimers and Hyperbranched Polymers | 2021-2025 | 476 | PL 23 | 61.29 |
| Surgical Sutures and Adhesives | 2021-2025 | 874 | PL 8 | 54.68 |
| Electromagnetic Effects on Materials | 2021-2025 | 534 | PL 4 | 27.52 |
